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Summary. In psoriatic arthritis, permanent joint damage characterizes disease progression and
represents a major debilitating aspect of the disease.Understanding the process of joint damage
will assist in the treatment and disease management of patients. Multistate models provide a
means to examine patterns of disease, such as symmetric joint damage. Additionally, the link
between damage and the dynamic course of disease activity (represented by joint swelling and
stress pain) at both the individual joint level and otherwise can be represented within a correl-
ated multistate model framework. Correlation is reflected through the use of random effects for
progressive models and robust variance estimation for non-progressive models. Such analyses,
undertaken with data from a large psoriatic arthritis cohort, are discussed and the extent to which
they permit causal reasoning is considered. For this, emphasis is given to the use of the Brad-
ford Hill criteria for causation in observational studies and the concept of local (in)dependence
to capture the dynamic nature of the relationships.
Keywords: Bradford Hill criteria; Causality; Composable Markov process; Damage; Disease
activity; Dynamic modelling; Granger causality and non-causality; Interval censoring; Local
dependence and independence; Multistate models; Psoriatic arthritis; Random effect; Robust
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1. Introduction
From a clinical perspective, it is generally held that better understanding of a disease process
will lead to more appropriate treatment and disease management of patients. Often multistate
models (Hougaard, 1999; Commenges, 1999; Andersen and Keiding, 2002; Meira-Machado
et al., 2009) are particularly useful for this. In this paper we illustrate their use for the study of
disease progression in psoriatic arthritis.
In his 1970 seminal paper, Schweder (1970) introduced the concept of local (in)dependence
between components of a composable finiteMarkov process. He felt thatmany studied phenom-
ena can be realistically described by time continuous finite Markov processes. If, in addition, the
Markov process representing the phenomenon under study could be defined to be composable
(i.e. represented as a vector of distinct subprocesses, whereby no two subprocesses or compo-
nents can change state ‘simultaneously’), then (in)dependences between these subprocesses can
be explicitly expressed through the transition intensities of the original Markov process.
More explicitly, let Y be a composable finite Markov process with components Y1, . . . ,Yp,
which we denote as Y ∼ .Y1, . . . ,Yp/, and let V = {1, . . . ,p}. Here the dependence on time in
the notation is left out for convenience but is implicit. A component Yk is said to be locally
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independent of Yj, j =k, given the remaining components YV\{j,k}, if and only if the transition
intensities of Y corresponding to transitions only between states in Yk are constant functions
for any state in Yj, within a specified infinitesimal time interval. If Yk is not locally independent
of Yj, it is said to be locally dependent on Yj.
The above relationship is a ‘local’ property as it holds in an infinitesimal time interval. Further-
more, recall that, because Y ∼ .Y1, . . . ,Yp/ is composable, no two components of Y can change
stateatthesametimeoverthis infinitesimal intervalandthereforethetransitionintensitiesforsuch
simultaneous transitions inmore than one component are zero.Moreover, local independence is
an asymmetric relationship, i.e. it has a direction, and so, Yk being locally independent of Yj does
notnecessarily imply thatYj is locally independentofYk over the same infinitesimal time interval.
This important concept of local independence was extended in Aalen (1987) to apply to more
general stochastic processes that admit a Doob–Meyer decomposition, with unrelated innova-
tions. Aalen stressed the usefulness of ‘dynamic’ models where dynamic refers to how the future
relates to the past, and it is this dynamic nature of Schweder’s work, rather than the Markov
assumption per se, which he suggested is important for statistical analysis. Earlier works by Cox
(1972) and Aalen et al. (1980) also reflect this dynamic viewpoint. More recently, Didelez (2007,
2008) introduced dynamic graphical models to describe these local dependences, which further
allowed local independences to be read off. In our discussion of the progression of psoriatic
arthritis disease that follows, we use Schweder’s local (in)dependence concept as a means of
characterizing the findings from dynamic analyses based on multistate models.
Because we focus on arthritic disease progression at the individual joint level, our analysis is
based on the use of correlated multistate models. Cook et al. (2004) considered such an analysis
for progressive processes but with a discrete multivariate random-effects distribution used to
account for correlation. For a four-state progressive model, we extend this to allow the use
of gamma-distributed random effects. In addition, for a three-state model with some reversible
transitions, we outline an approach that is based on generalized estimating equations to account
for correlation between processes.
Our reported investigations are based on observational clinical data and it is well recognized
that causal relationships can never be proved with such data. However, as Weiss (1986) argued,
‘it is necessary to attempt todraw inferences of cause and effect, even from inevitably incomplete data, for
the alternative is to make no inference at all, which would preclude taking preventive or therapeutic
action’.
Therefore, after presenting results of our analyses, we consider the extent to which they might
allow inference concerning causal relationships. In doing so, we take up the implied challenge
of Aalen (Aalen et al. (2008), page 348) who wrote:
‘Onemajor danger of avoiding the subject of causality in statistical education and statistical literature, is
that one never gets any insight into this fascinating concept, which has such an old history in philosophy
and science. The fact is that statistics plays a major role in looking for causal connections in many fields
and statisticians who know next to nothing about causality as a larger concept will be far less useful
than they could have been.’
After 30 years of data collection and 20 years of previous analyses, it seems particularly appro-
priate to take up this challenge with the psoriatic arthritis cohort data that are discussed in the
next section.
2. Psoriatic arthritis
2.1. Background
Psoriatic arthritis is an inflammatory arthritis associated with psoriasis, which is usually sero-
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negative for rheumatoid factor (Wright and Moll, 1976; Gladman, 2004). It is distinguished as
an entity from the prototypal arthritis, rheumatoid arthritis (RA), because of its unique clinical
features: the association with the skin disease psoriasis; equal gender frequency, as opposed to
the preponderance in females in RA; the asymmetric presentation involving large joints and
distal interphalangeal joints which are not commonly affected in RA; the majority (more than
85%) of psoriatic arthritis patients lack rheumatoid factor; roughly half of the patients with pso-
riatic arthritis have spinal involvement which is distinctly rare in RA. Moreover, in the fingers,
patients with psoriatic arthritis demonstrate dactylitis, or inflammation of the whole digit, as
well as enthesitis and other extra-articular features that are typical to the seronegative spondy-
loarthritides. Recent studies have demonstrated that psoriatic arthritis is a progressive disease,
leading to joint destruction, disability and reduced quality of life (Husted et al., 2001; Kane
et al., 2003; McHugh et al., 2003; McKenna et al., 2004; Queiro-Silva et al., 2003; Sokoll and
Helliwell, 2001).
Disease progression in psoriatic arthritis, as with RA, is often taken to be reflected in the
accumulation and severity of damaged joints, evaluated either clinically or through radiographic
imaging (e.g. X-rays). Clinical damage is determined by the presence of a limitation in range
of movement of more than 20% of the range not related to the presence of joint effusion, the
presence of joint deformities, subluxation, flail joints or ankylosis (Siannis et al., 2006). The
damage process is generally irreversible; therefore once a joint is damaged it will remain so; thus
efforts by clinicians to prevent or slow this process are crucial in the care of patients. Disease
activity, in contrast, is a reversible process, and is reflected in part by joints being described
as either tender (the presence of stress pain and/or joint line tenderness) only or effused (joint
swelling with or without tenderness), with the latter representing a more severe level of activity
than the former. Various types of medication are available to treat the disease activity. The use
of non-steroidal anti-inflammatory drugs and disease modifying anti-rheumatic drugs as first-
and second-line treatments, and more recently biologics that bind to tumour necrosis factor α,
preventing activation of its receptors, are all available in the clinician’s arsenal ofmedications for
controlling the activity of the disease. In addition, if these front-line therapies are not effective
at reducing inflammation, the use of intra-articular steroids injected directly into the specific
active joint(s) may also be considered.
In 1978, the Toronto Psoriatic Arthritis Clinic was established by Professor Dafna Gladman
at the University of Toronto after recognizing that there was a paucity of knowledge regarding
psoriatic arthritis at the time. Since then, much has been learned about the disease through
research done at the Toronto Psoriatic Arthritis Clinic, which has the largest and most com-
prehensively studied cohort of psoriatic arthritis patients in the world. At present, the clinic
includes over 1000 patients who have been closely followed up prospectively over the years.
Visits to the clinic are aimed to be scheduled 6–12 months apart. At these visits, patients are
evaluated in a standard way according to a defined protocol that includes a complete history,
physical examination (including rheumatological assessment) and routine blood and urine tests,
with X-rays also being performed biennially. The rheumatological examination includes vali-
dated and reliable determination of active and damaged joints. This longitudinal information
provides a valuable resource for research.
Up to the end of 2006, which, in the main, was the period predating the introduction of
biologics, longitudinal data on 790 patients were collected from the Toronto Psoriatic Arthritis
Clinic. A subset of 517 patients, which is defined in Section 3, of the 790 will be used in this
study to examine patterns of disease and to investigate the link between clinical damage and the
dynamic course of disease activity at both the individual joint level and otherwise. Of these 517
patients, 289 (55.9%) were male and 228 (44.1%) female. The mean age at entry was 41 years
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and 7 months, with a standard deviation of 12 years and 7 months. The number of visits to the
clinic recorded up to 2006 ranged from 2 to 47, with a median of 7. The mean gap time (i.e.
the time between successive clinic visits) was 10.8 months (standard deviation 15.2 months) and
the median gap time was 6.3 months.
2.2. Previous investigations
For both psoriatic arthritis and RA there is a strong belief among clinicians that active inflam-
mation (i.e. persistent inflammatory synovitis) results in or causes joint damage. A number of
research groups have repeatedly shown an association between disease activity and progression
to damage in both psoriatic arthritis and RA, with this association consistently seen irrespec-
tively of the measure of activity used (i.e. whether it be the number of active (tender or effused)
joints, biochemical markers or some form of composite measure of disease activity) or whether
damage is determined radiologically or clinically (Aletaha et al., 2009; Bond et al., 2007; Glad-
man et al., 1995; Gladman and Farewell, 1999, Molenaar et al., 2004; Mulherin et al., 1996;
Scott, 2004; Smolen et al., 2009; Welsing et al., 2004).
For psoriatic arthritis, it has been found that radiological damage precedes clinical damage in
themajority of patients (Siannis et al., 2006), and that the same predictors of disease progression
are seen regardless of how damage is detected (Bond et al., 2007). In a recent investigation of the
link between activity and damage in psoriatic arthritis based on the Toronto Psoriatic Arthritis
data (Bond et al., 2007; Bond and Farewell, 2009), negative binomial regression models for
the increase in the total damaged joint count between visits were fitted, with previous damage
incorporated as a dynamic explanatory variable in the models to account for the within-patient
correlation. Disease activity was included initially in these models both in terms of total active
joint counts (effused and tender) at entry to the clinic and as time-dependent explanatory vari-
ables, with the total joint counts updated at visits to the clinic. These models found that time
varying activity (both effused and tender total joint counts) was associated with the progression
of radiological and clinical damage, but that activity variables at entry to the clinic were not,
when in the presence of their time varying counterparts.
These results, coupled with similar results in RA, argue for a close link between activity
and damage, which, additionally, is supported by the time ordering. This argument is further
strengthened by the dose–response nature of the relationship between activity and damage. In
our recent psoriatic arthritis investigation, differential effects of tender-only joint and effused
(usually also tender) joint counts were found to some extent, with the relative rate estimate for
the more severe effused joint count larger than the relative rate estimate for tender joint count.
Similar findings were reported in a recent study inRA, in which a positive association was found
between the level of disease activity (defined by using the simplified disease activity index) and
the level of radiographic progression (defined by using the modified total Sharp score) (Aletaha
et al., 2009).
However, because total joint counts or other ‘global’ measures of disease activity and damage
are used, the link that was found between activity and damage is essentially between the systemic
activity process and the systemic damage process. If we can consider a finer level of detail and
examine the link at the individual joint level then similar resultswould further our understanding
of the relationships between activity and damage. Additionally, issues that are related to disease
patterns can be investigated.
3. Four-state model for damage process
Clinical damage and disease activity information at the individual joint level for the hands
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Fig. 1. Diagram showing the 14 hand joints and their type
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Fig. 2. Diagram of the multistate model for damage at a joint location, with random effect
(excluding the wrist joints) was extracted from the Toronto Psoriatic Arthritis Clinic’s database.
Fig. 1 shows a picture of the 14 joints in a hand. In it, three types of joint are seen: the distal
interphalangeal, the proximal interphalangeal and the metacarpophalangeal. All three joint
types are usually found on a digit, except for the thumb where the distal interphalangeal joint
is absent. There are 28 hand joints in total.
For the purposes of this paper, we use data extracted from 517 of the 790 patients in the clinic
who entered before the beginning of 2007. These 517 patients correspond to those who, at entry
to the clinic, had no clinical damage in any of the hand joints on either the left or right hands and
therefore information on all these patients is comparable. The clinical damage processes at the
hand joint level may be observed in either of two states at a clinic visit (‘not damaged’ or ‘dam-
aged’). However, once a hand joint enters the damaged state it remains there ad infinitum, i.e.
the damaged state is absorbing, and all the individual joints’ damage processes are irreversible.
Disease activity at a specific hand joint is defined by two joint-specific processes: a tender-only
joint process and an effused joint process. Both these two activity processes are reversible. The
tender joint process can move back and forth between a state of ‘no stress pain’ and a state
of ‘tenderness only’. The effused joint process can move between states of ‘no swelling’ and
‘effusion’.
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The multistate model for our first set of analyses is depicted diagrammatically in Fig. 2 and
is a four-state model for damage in each of the 14 pairs of hand joints. The four states of this
multistate model are defined as
(a) state 1, damage in neither hand, .D¯L, D¯R/,
(b) state 2, damage in the right hand only, .D¯L,DR/,
(c) state 3, damage in the left hand only, .DL, D¯R/, and
(d) state 4, damage in both hands, .DL,DR/.
This is a multistate model at a specific joint location in both left and right hands. Moreover,
it is composable, comprising separate damage subprocesses for the left and right hands at the
specific joint location, and local dependences between the subprocesses will be reflected in rela-
tionships between the transition intensities of this multistate model. In addition, this model
does not allow transitions directly from state 1 to state 4. This is a necessary constraint to
ensure composability but is not very restrictive for models with transitions in continuous time.
Transitions between state 2 and state 3 are not allowed since damage is irreversible. Further-
more, because the 14 multistate processes within a patient should be more similar than across
patients, we introduce subject-specific random effects into the model. These act multiplicatively
on the baseline transition intensities of the 517 patients. The random effects, Uk, k=1, . . . , 517,
are assumed to be distributed as independent gamma random variables with unit mean and
variance θ (see equation (6) in Appendix A), which we denote by Uk ∼gamma.1=θ, 1=θ/.
To be more precise, consider the continuous time multistate process for damage, X.l/k =
{X.l/k .t/|t ∈Tk}, at the lth joint location for the kth patient, with state space Ω= {1, . . . , 4} as
described above, and Tk = [0, τk/ being the time interval of interest. Here the timescale is time
from entry to the clinic in years. Let λ.l/ijk.t/ be the transition intensity function that is associated
with X.l/k corresponding to the transition from state i to state j, denoted as i→ j, where i = j
(i= 1, 2, 3; j = 2, 3, 4) and with transitions 1→ 4, 2→ 3 and 3→ 2 not permissible. Let λ.l/0ij be
the baseline transition intensity corresponding to this i → j transition. In addition, let β.l/ij
be a vector of regression parameters that are associated with the predictable explanatory vari-
able vector process z.l/ijk.t/. Then the transition intensity function for the i→ j transition, i = j,
at the lth hand joint location for the kth patient is given by
λ
.l/
ijk{t|β.l/ij , z.l/ijk.t/,uk}=ukλ.l/0ij exp{β.l/Tij z.l/ijk.t/}, .1/
where uk corresponds to the subject-specific random effect. This multistate model is a general-
ization of Schweder’s model to incorporate random effects and is similar to the model that was
proposed by Cook et al. (2004) for clustered progressive multistate processes. Nevertheless, this
model still allows us to examine local dependences through the transition intensities. Note that
we have assumed that the regression parameter vector β.l/ij is joint location specific. However,
it may be reasonable to set β.l/ij =βij as the 14 joint location processes represent a similar dis-
ease progression phenomenon, and we do this subsequently. Also it may at times be sensible to
constrain baseline intensities to be the same across some joint locations for parsimony, and we
shall indicate when this has been done. Moreover, further constraints on regression parameters
may be acceptable for simplification based on the analyses of the data.
3.1. Maximum likelihood estimation
We employ an underlying time homogeneous Markov model for panel data where patients
are not under continuous follow-up and are observed only at protocol visits (Kalbfleisch and
Lawless, 1985), and with baseline transition intensities modulated by the effects of explanatory
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variables z.t/ and subject-specific random effects {uk} as described in model (1). Suppose that
the kth patient makes nk clinic visits at times tk = .tk1, . . . , tknk /T and associated with the lth joint
location process for this patient are an explanatory variable vector process z.l/k .t/ recorded at
clinic visits, baseline transition intensities λ.l/0 = .λ.l/012,λ.l/013,λ.l/024,λ.l/034/T and a vector of regres-
sion parameters β.l/. Then the conditional probability of observing the path that is followed by
the lth joint location process of the kth patient over the nk clinic visits, given uk, is
nk−1∏
m=1
P{X.l/k .tk,m+1/|X.l/k .tkm/,uk;λ.l/0 ,β.l/, z.l/k .tkm/}
and thus the overall likelihood contribution from the kth patient is given by
Lk.λ0,β, θ/=
∫ ∞
0
[
14∏
l=1
nk−1∏
m=1
P{X.l/k .tk,m+1/|X.l/k .tkm/,uk;λ.l/0 ,β.l/, z.l/k .tkm/}
]
fUk.uk/duk,
where λ0 = .λ.1/T0 , . . . ,λ.14/T0 /T, β = .β.1/T, . . . ,β.14/T/T and fUk .uk/ denotes the probability
density function of the gamma.1=θ, 1=θ/ distribution. (The integration over the random-effect
distribution canbe carried out inR (RDevelopmentCoreTeam, 2009) by using theintegrate
command.) Hence the likelihood function across all N individuals is given by
L.λ0,β, θ/=
N∏
k=1
Lk.λ0,β, θ/: .2/
We maximize the log-likelihood of equation (2) with respect to the baseline transition inten-
sity parameters λ0, the regression parameters β and the random-effect variance θ. This is done
by using the BFGS optimization routine (Broyden, 1970) through the optim command in R.
This yields parameter estimates together with a numerically derived Hessian matrix at the esti-
mate values from which asymptotic standard errors for the parameter estimates are obtained.
Comprehensive details of the likelihood function are provided in Appendix A.
In the following subsections, we describe analyses that use the four-state model to investigate
firstly the extent to which a symmetric disease pattern exists in the hands of psoriatic arthritis
patients and then the relationship between activity and damage at the joint level.
3.2. Patterns—symmetric joint damage in the hands
In RA, there is a consensus among rheumatologists that damage is highly symmetric. This,
however, is not so for psoriatic arthritis, where there is still uncertainty among rheumatologists
concerning the extent of symmetry (Gladman, 2005, 2006). To inform this debate, at least with
regard to the hands of psoriatic arthritis patients, we analyse the data from the 14 pairs of
joints within each of the 517 patients by using the correlated multistate processes model that
was described earlier. Table 1 presents the observed transition table for this model. We find
that there were 70169 observed transitions, of which only 687 were actual transitions between
differing states, over all pairs of joints in the 517 patients, with 813 hand joints becoming dam-
aged over the follow-up period of the study out of the possible 14476 total hand joints under
investigation.
To investigate the extent of disease symmetry in the hands we set the explanatory vector
z.l/ijk.t/=0 in equation (1) and reparameterize some of the baseline transition intensities in terms
of others, i.e. we specify λ.l/024 =λ.l/013 exp.γ24/ and λ.l/034 =λ.l/012 exp.γ34/. Therefore a test for sym-
metry would require λ.l/012 <λ
.l/
034 and λ
.l/
013 <λ
.l/
024, or equivalently that γ24 > 0 and γ34 > 0, i.e.
a symmetrical damage pattern implies that the tendency for a joint at a specific location to
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Table 1. Observed joint transitions for the four-state multistate model
Transition from Number of transitions to the following states:
(D¯L,D¯R) (D¯L,DR) (DL,D¯R) (DL,DR)
.D¯L, D¯R/ 66729 225 204 126
.D¯L,DR/ 0 1339 0 81
.DL, D¯R/ 0 0 1414 51
.DL,DR/ 0 0 0 0
become damaged is increased if the contralateral joint on the other hand is earlier damaged,
and this applies at all joint locations. Note that the usage of symmetry here is a rheumatological
usage and does not refer to the technical use of the term symmetry in statistics to describe
the invariance of cell probabilities in the permutation of the subscripts indexing these values,
as when applied to describing some statistical models based on repeated categorical response
data.
Table 2 presents the results from fitting the model to investigate symmetry. The parameters
γ24 and γ34 are estimated to be 1.82 and 1.39 respectively with corresponding 95% confidence
intervals of .1:49, 2:14/ and .1:01, 1:78/. Both of these confidence intervals indicate substantial
departures from zero to the right and therefore present strong evidence for symmetry. This
symmetry, in turn, implies that there are local dependences in both directions between the two
damage subprocesses (i.e. the left and the right) of the composable multistate process.
We now consider whether the relationship between disease activity and damage, which is
repeatedly found at the patient level, is seen at the individual joint level.
3.3. Regression of activity on damage at joint level
To investigate the relationship between damage and the dynamic course of disease activity at the
individual joint (location) level we use the model represented by equation (1) with the explana-
tory variable vector process z.t/ defined by information on activity. We define binary indicators
of joint level activity, AL.t/ and AR.t/ for the left and right joints respectively in a pair at time
t. In these variables, we make no distinction between activity in the form of tenderness and
effusion. However, for transitions into a state of damage, we are interested in assessing a
possible dose–response relationship between joint activity and the rate at which damage
occurs. Thus we also define dynamic binary indicators for joint level tenderness only, TL.t/
and TR.t/, and joint level effusion (with or without tenderness but usually tender), EL.t/ and
ER.t/, for the left (L) and right (R) hands at time t.Hence, assuming that noprevious damage has
occurred to either joint (state 1), models for the transition intensities out of state 1 are given
by
λ
.l/
12k.t/=ukλ012 exp{αL12A.l/L .t/+ τR12T .l/R .t/+ "R12E.l/R .t/},
λ
.l/
13k.t/=ukλ013 exp{αR13A.l/R .t/+ τL13T .l/L .t/+ "L13E.l/L .t/}
.3/
where β12 = .αL12, τR12, "R12/T, β13 = .αR13, τL13, "L13/T and we assume that the baseline tran-
sition intensities are constrained to be the same across the 14 hand joint locations.
When forming models for the transition intensities into state 4, we choose not to include
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Table 2. Parameter estimates together with
associated 95% confidence intervals (in paren-
theses) for the model fitted to investigate sym-
metry in the left and right damage processes†
Joint λˆ012 (×10−2) λˆ013 (×10−2)
MCP1 0.91 0.34
(0.65, 1.29) (0.20, 0.57)
MCP2 0.31 0.17
(0.19, 0.52) (0.08, 0.33)
MCP3 0.20 0.36
(0.11, 0.37) (0.22, 0.59)
MCP4 0.62 0.63
(0.41, 0.94) (0.42, 0.95)
MCP5 0.35 0.68
(0.21, 0.58) (0.46, 1.02)
PIP1 0.95 0.78
(0.65, 1.38) (0.53, 1.15)
PIP2 0.66 1.16
(0.44, 0.99) (0.82, 1.64)
PIP3 0.67 0.30
(0.47, 0.97) (0.19, 0.49)
PIP4 0.34 0.20
(0.21, 0.56) (0.11, 0.37)
PIP5 0.20 0.37
(0.11, 0.37) (0.23, 0.59)
DIP2 0.50 0.57
(0.33, 0.77) (0.37, 0.87)
DIP3 0.41 0.36
(0.26, 0.64) (0.23, 0.56)
DIP4 0.96 0.82
(0.66, 1.39) (0.55, 1.22)
DIP5 0.74 0.42
(0.50, 1.10) (0.27, 0.65)
†The estimate for the random-effect variance
is θˆ = 4:99 .3:97, 6:27/. Estimates for the sym-
metry parameters are γˆ24 = 1:82 .1:49, 2:14/ and
γˆ34 = 1:39 .1:01, 1:78/. MCP, metacarpophalan-
geal; PIP, proximal interphalangeal; DIP, distal
interphalangeal.
information (in the form of explanatory variables) on the activity process in the opposite (dam-
aged) joint at time t because of the dominant effect of symmetrical damage. Hence, our models
for the transition intensities into state 4 are given by
λ
.l/
24k.t/=ukλ024 exp{τL24T .l/L .t/+ "L24E.l/L .t/},
λ
.l/
34k.t/=ukλ034 exp{τR34T .l/R .t/+ "R34E.l/R .t/}
.4/
with β24 = .τL24, "L24/T, β34 = .τR34, "R34/T and, once again, we assume that the baseline tran-
sition intensities are constrained to be the same across the 14 joint locations.
Because of the panel nature of the data, we focus on the relationship between observed tran-
sitions in the damage process and the values of these activity variables (which are represented
by activity or joint pain and swelling on both the left and the right hands) at the last clinic visit,
i.e. we assume that AL.t/, AR.t/, TL.t/, TR.t/, EL.t/ and ER.t/ are piecewise constant between
684 A. G. O’Keeffe, B. D. M. Tom and V. T. Farewell
clinic visits. Thus underlying activity is assumed to be coarsened by the timing of clinic visits.
We additionally assume that these activity variables can only change ‘state’ immediately after
the time of a visit to the clinic when damage information becomes available.
It is ‘biologically’ conceivable that this model, given by expressions (3) and (4), can be
further constrained to allowαL12 =αR13, τR12 =τL13, τL24 =τR34 and, similarly, "R12 ="L13 and
"L24 = "R34. We applied these constraints to subsequent models in the interest of parsimony.
However, the analysis that was just described did not fully exploit the dynamic potential of
the framework being used, as it only used the current visit activity information when predicting
future damage. It is quite plausible that some measure(s) of the ‘activeness’ of the joint over time
may better characterize the relationship between activity and damage at the joint level, since
more of the history of the disease activity process can be incorporated. For illustration, in a fur-
ther analysis, we added binary explanatory variables (for joints on the left and right hands) that
now indicate whether a joint was ever observed active (either swollen or tender) at the present
visit or any of the previous protocol visits. We included similar constraints on the explanatory
variables (i.e. ρL12 =ρR13, ρR12 =ρL13 and ρL24 =ρR34, where ρ is the coefficient corresponding
to whether or not the joint has ever been active) and allowed only prior activity in the undam-
aged joint to have an effect on the corresponding transition into state 4 (i.e. ρL34 = ρR24 = 0).
We considered the possibility of an effect of activity at other joints on the damage rates by
including binary explanatory variables to indicate whether or not activity occurred at any other
joint in the same hand and whether or not activity occurred at any other joint in the opposite
hand. The addition of these explanatory variables produced no demonstrable effect and they
were subsequently removed from the model. Furthermore, we also fitted this model including a
four-level factor to account for joint type (levels: finger metacarpophalangeal, proximal inter-
phalangeal and distal interphalangeal and thumb metacarpophalangeal) with each level of this
variable constrained to have the same effect across all transitions. However, this was found not
significantly to affect any of the transitions to damage and was subsequently removed from the
model. Some previous analyses (e.g. Bond et al. (2007)) have suggested that the erythrocyte sed-
imentation rate is one of the most likely patient confounders for a relationship between activity
and damage in the hand joints. Thus, we fitted a model that included an explanatory variable
to represent time varying erythrocyte sedimentation rate, constrained to have the same effect
across all transitions. The inclusion of this explanatory variable did not change substantially the
estimated effects of the activity explanatory variables on the transitions to damage, and hence
the time varying erythrocyte sedimentation rate variable, for which there was also no evidence
for an effect in this model, was not included in our final model.
Table 2 shows variation in baseline transition intensities fitted to each joint location but no
obvious patterns. We considered the fitting of joint-location-specific transition intensities in our
final model. However, such a model would require a large number of extra parameters to be
estimated together with their associated standard errors. This would be challenging computa-
tionally and the relatively low number of transitions from states 2 and 3 to state 4 (shown in
Table 1) may result in unstable parameter estimates. We take the view that some assumptions
must bemadewith regard to parameter constraints in the interests of parsimony. The inability to
model differences in the baseline rates among the joint locations easily and the need to maintain
sufficient parsimony are practical limitations of this model.
Tables 3 and 4 present the results of fitting the constrained model including previous activity
to 510 of 517 patients included in the earlier ‘symmetry’ analysis. Seven patients were excluded
owing to missing information on disease activity. In Table 3 ‘transitive’ joint refers to the joint
undergoing the transition to a state of damage (i.e. to state 2, 3 or 4) and ‘opposite’ joint refers to
the same joint in the opposite hand. From Table 3, where there is no previous damage in either
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Table 3. Log-intensity ratio and intensity ratio estimates for activity at the
individual joint level, together with associated 95% confidence intervals (in
parentheses)
Effect on transition to damage Estimate Intensity ratio
No previous damage in either joint
Tenderness in the transitive joint 1.01 (0.72, 1.31) 2.76 (2.06, 3.70)
Effusion in the transitive joint 1.50 (1.22, 1.77) 4.47 (3.38, 5.90)
Activity in the opposite joint 0.17 (−0.10, 0.44) 1.18 (0.90, 1.55)
Transitive joint active in the past 0.76 (0.52, 1.00) 2.14 (1.68, 2.71)
Opposite joint active in the past 0.10 (−0.15, 0.35) 1.10 (0.86, 1.41)
Opposite joint damaged
Tenderness in the transitive joint 0.81 (0.41, 1.20) 2.24 (1.51, 3.32)
Effusion in the transitive joint 0.78 (0.34, 1.23) 2.19 (1.40, 3.41)
Transitive joint active in the past 0.31 (0.01, 0.62) 1.37 (1.00, 1.86)
Table 4. Baseline intensities λ and random-effect
variance parameter θ, together with associated 95%
confidence intervals (in parentheses)
Parameter Estimate 95% confidence
(×10−2) interval (×10−2)
λ012 0.28 (0.21, 0.36)
λ013 0.27 (0.21, 0.34)
λ024 2.15 (1.49, 3.10)
λ034 2.34 (1.58, 3.47)
θ 3.81 (2.98, 4.88)
joint (i.e. the model is currently in state 1), we observe increases in the rates of transitions into a
state of damage when there is current activity (in the form of both tenderness and effusion) and
when there has been some past activity in the transitive joint, compared with when no activity
has been seen. We note that effusion shows a larger positive effect on transition to damage than
tenderness. Conversely, activity in the opposite joint appears not to affect the transition rate
to damage significantly. Where the opposite joint is already damaged we see an increase in the
transition to damage both where there is current tenderness and where there is current effusion
as well as where past activity has occurred in the transitive joint. We note that the effects of
tenderness and effusion are similar; we no longer see an apparent dose–response relationship
for the covariates representing activity in the transitive joint. This perhaps indicates that, when
the opposite joint becomes damaged, the damage process in a joint is more complicated than
when no such opposite damage exists and may be significantly influenced by other biological
processes.
The log-intensity ratios of the six transitive association effects that were described in the previ-
ous paragraph are all positive and large, with probable differential effects observed between the
comparable transitions for tender-only and the more severe effused (usually also tender) joints,
ipsilaterally, where no damage has occurred to the opposite joint. The effects corresponding to
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effusion tend to be larger than the comparable effects for tender-only joints, ipsilaterally, again
where no damage has occurred to the opposite joint. These six association effects are all the
statistically significant effects that were found and the four corresponding to current activity
suggest that the link between activity and damage is local or specific to the joint on the par-
ticular hand being considered. These four associations are what we would consider as a local
dependence or influence of activity on damage at a joint. We do not observe any statistically
significant association, or evidence of a possibly substantive effect, of having or not having
activity in a joint on one hand with having or not having damage on the contralateral joint of
the other hand.
All the analyses that are reported in this subsection treated the disease activity process as
explanatory variables and the damage process as the outcome. In addition, the various activity
explanatory variables were treated as remaining constant between clinic visits. Such models
are extremely important because the explanatory variables represent the information that is
available to clinicians in managing a patient’s disease. However, if the aim is to understand
the relationship between activity and damage at a more fundamental level, then it is impor-
tant to recognize that the disease activity process can be a highly variable and dynamic process
(especially when medication is available to treat disease activity). Therefore, with intermittently
measured activity (as well as damage) and possibly highly variable gap times between clinic
visits, the assumption of piecewise constancy of explanatory variables may be unsuitable for
some purposes.
In the next section, we address this concern by considering a multistate model which jointly
defines the activity and damage processes (i.e. both activity and damage are treated equally as
outcomes).
4. Three-state model for activity–damage process
To characterize better the temporal relationship between activity and damage, we propose a
new three-state model for each of the 28 phalangeal joints across the left and right hands of a
psoriatic arthritis patient. The three states of this model, which combines activity and damage
events, are defined as
(a) state 1, no damage .D¯/ and no activity .A¯/ in the joint,
(b) state 2, no damage .D¯/ and activity (A) in the joint, and
(c) state 3, damage .D/ in the joint.
A diagrammatic representation of this model is shown in Fig. 3. Transitions between states 1
and 2 (i.e. between the ‘activity’ states) are permitted. The damage state (i.e. state 3) is absorbing
and therefore follow-up for a specific joint ends when damage occurs. Thus, observation of the
multistate process for a joint is stopped either when damage occurs or at the last visit to the
clinic.
Correlation between the 28 multistate joint processes within the hands of a psoriatic arthritis
patient is expected and this within-patient correlation needs to be incorporated in the model.
However, because of the reversibility of transitions between activity states, it is computationally
difficult to introduce subject-specific random effects into this model as done for the four-state
model of Section 4. Whereas Cook et al. (2004) achieved this with a simple discrete distri-
bution for the random effects in the progressive multistate model setting, we instead adopt a
‘generalized estimating equation’ approach to estimation, in which we assume a working inde-
pendence correlation structure for the 28 correlated multistate hand joint processes within a
patient, and then calculate robust standard errors for the estimated parameters through use of
Clinical Epidemiology of Psoriatic Arthritis 687
1No Joint Activity
No Joint Damage
Joint Activity
No Joint Damage
Joint Damage
23
13
1221
2
3
D
DA 
D A
Fig. 3. Diagram of the multistate model for the activity and damage combined process
the robust information sandwich matrix (Cox, 1961; Huber, 1967; White, 1982; Royall, 1986).
Our approach is similar to that employed in Lee and Kim (1998) but now for non-progressive
clustered processes.
The analysis is performed by using the msm package (Jackson, 2008) in R, which implements
a standard maximum likelihood estimation approach for multistate models with panel data
(Kalbfleisch and Lawless, 1985). This package allows the user to specify explanatory variable
effects to act on certain transition intensities only and yields maximum likelihood estimates for
the baseline transition intensities and explanatory variable effects. We extract a score vector
for each patient, calculated at the maximum likelihood estimates, together with the numerically
derivedHessianmatrix from theoptimization in themsmpackage toobtain anasymptotic robust
variance–covariance matrix for the maximum likelihood estimates, using a method presented
in Cook and Lawless (2007) (page 342). This robust variance–covariance matrix accounts for
the correlation between joints without the use of a subject-specific random effect.
More precisely, we consider for the kth patient at the pth phalangeal joint of the hands
(p = 1, . . . , 28), a multistate process X.p/k = {X.p/k .t/|t ∈ Tk}, with state space Ω= {1, 2, 3} as
described above, and Tk = [0,T .p/Sk ∧τk/ denoting the time interval of interest (measured in years)
which begins at entry to the clinic and stops at the visit to the clinic where damage in the pth
phalangeal joint is first observed, if it occurs, or else stops at the last visit to the clinic. Let λ.p/ijk .t/
be the transition intensity function associated with X.p/k corresponding to the transition i→ j,
where i = j (i=1 or i=2; j=1, 2, 3). Let λ.p/0ij be the baseline transition intensity corresponding
to this i→ j transition. In addition, let β.p/ij be a vector of regression parameters associated with
the predictable explanatory variable vector process z.p/ijk .t/. Then the transition intensity function
for the i→j transition, i =j, at thepthphalangeal joint of thehands for thekthpatient is givenby
λ
.p/
ijk {t|β.p/ij , z.p/ijk .t/}=λ.p/0ij exp{β.p/Tij z.p/ijk .t/}: .5/
For parsimony and because we believe that these 28 multistate activity–damage processes de-
scribe a similar phenomenon, we assume that β.p/ij =βij and that λ.p/0ij =λ0ij in equation (5).
The analysis of the individual joint level data which uses this three-state model is described
in the next subsection. The analysis is based on the 510 patients with complete joint level infor-
mation on activity and damage.
4.1. Jointly modelling activity and damage at joint level
The observed joint transition table for the three-state model that is illustrated in Fig. 3 is shown
in Table 5. There are 134295 observed joint transitions among all the hand joints from the
510 patients. This corresponds to approximately nine transitions observed per patient hand
joint. The actual number of observed transitions between differing states was 14856. By the
end of the study period 772 hand joints were damaged, which corresponds to 5% of all 14280
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Table 5. Observed joint transitions for the three-state
activity–damage multistate model
Transition Number of transitions to the following states:
from
(A¯,D¯) (A,D¯) D
.A¯,D¯/ 113793 6765 510
.A,D¯/ 7319 5646 262
D 0 0 0
(=28×510) hand joints. The total hand-joint-years of follow-up until damage or administrative
censoring was 122008.6 years, and the observed rate of hand joint damage is six joints per 1000
hand-joint-years of follow-up.
We fit to these data the three-state model defined in equation (5), with a five-level factor
variable for type of joint (i.e. metacarpophalangeal, proximal interphalangeal, distal interphal-
angeal, metacarpophalangeal 1 and proximal interphalangeal 1—see Fig. 1), a time-dependent
explanatory variable indicating whether the joint at the previous visit to the clinic had ever been
observed active (at this visit or in the past) and a time-dependent variable indicating whether
or not the corresponding joint in the opposite hand is in a state of damage for z.t/. We fitted
this model with explanatory variable effects on all transitions and performed Wald tests, using
the robust variance–covariance matrix, to determine whether or not effects on all transitions
were required. As a result, the time-dependent explanatory variable representing past activity
and the joint type factor were excluded from the equations for the transition intensities out of
state 2. Additionally, we parameterized the baseline 2→ 3 transition intensity in terms of the
baseline 1→3 transition intensity, i.e. λ023 =λ013 exp.γ/, adjusting for explanatory variables.
Table 6 shows the results of fitting this model. We observe strong evidence to support the
hypothesis that λ023 >λ013. This evidence is reflected in a large γ-estimate of 3.08 (robust 95%
confidence interval (1.76, 4.40)), which equates to an approximately 22 times greater transition
rate to damage from an active (but not damaged) state than from a state of non-activity (and
not damaged) just before the transition to damage, other factors being the same. In addition,
there is evidence of the ‘ever active’ variable being positively associated with the 1→2 and 1→3
transitions. Thus a joint ever being recorded as active before the current visit increases both the
baseline transition rates of making an instantaneous transition from a state of ‘no damage, no
activity’ to ‘no damage, activity’ and to ‘damage’. In controlling for damage in the same joint of
the opposite hand, we see that damage on the opposite hand has a significant effect only on the
transitions to damage (i.e. 1→3 and 2→3), further strengthening the argument for symmetric
damage seen in the previous four-state model.
The value exp.γ/=21:72 describes the ratio between λ23 and λ13 in the absence of damage to
the opposite joint. Since the effects of damage to the opposite joint are of similar magnitude, we
obtain a similar estimate of 21:72×7:50=7:19=22:65 for this ratio in the presence of damage to
the opposite joint. This concurs to some extent with the results from the four-state model which
showed that the presence of activity has a significant effect on the rate of transition to damage in
a joint where the same joint in the opposite hand already exhibits damage. Furthermore, we note
that there is a negligible effect of opposite joint damage on the 1→2 transition intensity. This
suggests that the apparent symmetric effect of opposite joint damage is not mediated through
an increase in disease activity but rather through another, unknown, mechanism.
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Table 6. Intensity ratio and baseline intensity parameter estimates together with associated naive
and robust 95% confidence intervals for the model that includes the effects of joint type, previous
activity on transitions from state 1 and opposite damage on all transitions
Parameter Estimate 95% confidence interval
Naive Robust
Baseline intensities (×10−2)
λ012 9.24 (8.19, 10.43) (6.76, 12.63)
λ013 0.14 (0.07, 0.30) (0.04, 0.49)
λ021 151.48 (146.10, 157.10) (126.25, 181.76)
Intensity ratios
exp.γ/ 21.72 (11.89, 39.69) (5.79, 81.46)
Metacarpophalangeal on 1→2 1.10 (0.99, 1.21) (0.82, 1.47)
Metacarpophalangeal on 1→3 0.37 (0.16, 0.86) (0.05, 2.75)
Proximal on 1→2 1.24 (1.12, 1.36) (0.96, 1.59)
Proximal on 1→3 1.04 (0.56, 1.94) (0.31, 3.52)
Distal on 1→2 0.86 (0.77, 0.95) (0.63, 1.16)
Distal on 1→3 2.82 (1.60, 4.96) (0.95, 8.36)
Thumb metacarpophalangeal on 1→2 1.26 (1.12, 1.42) (0.97, 1.63)
Thumb metacarpophalangeal on 1→3 2.68 (1.43, 5.04) (0.88, 8.13)
Joint ever active on 1→2 2.98 (2.84, 3.13) (2.13, 4.17)
Joint ever active on 1→3 3.07 (2.38, 3.96) (1.27, 7.40)
Opposite joint damage on 1→2 1.20 (1.01, 1.44) (0.64, 2.27)
Opposite joint damage on 1→3 7.19 (4.90, 10.54) (2.11, 24.44)
Opposite joint damage on 2→1 1.08 (0.91, 1.28) (0.64, 1.82)
Opposite joint damage on 2→3 7.50 (5.08, 11.09) (2.40, 23.46)
Further generalization of our three-state model to incorporate piecewise constant baseline
intensities resulted in some evidence for a decline in the transition rate from the state of ‘no dam-
age,noactivity’ (state1) to the stateof ‘nodamage,activity’ (state2)as the time inclinic increased.
However, no evidencewas found for changes over time in the transition rate from state 2 to state 1
and the two transition rates into the ‘damage’ state (state 3). Moreover the γ-estimates that were
obtained when the follow-up time period was stratified into three intervals either as [0, 1/, [1, 3/
and [3,∞/ or [0, 5/, [5, 10/ and [10,∞/ were 3.155, 3.015 and 2.714 or 3.048, 2.618 and 2.807
respectively. These estimates were well within the 95% robust confidence interval of 1.76–4.40
that was reported in the previous paragraph and provided no evidence for a marked change in γ
over time. Finally, therewas no demonstrablemodification of the estimated explanatory variable
effects in Table 6when these additional time inhomogeneous three-statemodels were fitted.
The analyses of this subsection againdemonstrate a local dependence at the joint level between
activity and damage (i.e. activity influences damage locally) and characterizemore fully the tem-
poral ordering.
5. Causality
5.1. Framework
In the section on ‘Assessing causality’ in a classic epidemiological text (Lilienfeld and Stolley,
1994) it is argued that
‘a relationship is considered causal whenever evidence indicates that the factors form part of the com-
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plex of circumstances which increases the probability of the occurrence of disease and that a diminution
of one or more of these factors decreases the frequency of the disease’.
Sir Austin Bradford Hill, in his 1965 Presidential address to the Section of Occupational
Medicine of the Royal Society of Medicine (Hill, 1965), discussed aspects of an association that
should be especially considered when attempting to infer causation in this sense from associa-
tion. These aspects, which are now referred to as the Bradford Hill criteria, are
(a) strength of association,
(b) consistency,
(c) specificity,
(d) temporality,
(e) biological gradient,
(f) biological plausibility,
(g) coherence,
(h) experimental evidence (when available) and
(i) analogy.
However, Hill never intended these ‘viewpoints’ to be ‘hard-and-fast rules of evidence that must
be obeyed before we can accept cause and effect’ (Hill, 1965). They are not necessary and/or
sufficient conditions to declare causation from an observed association, although temporality is
indisputably a necessary condition as a cause must precede its effect. They are, however, useful
in providing a structure when attempting to move from association to causation. In particular,
they (excluding criterion (h)) have been found to be valuable in epidemiological settings.
Schweder (1970) regarded his concept of local (in)dependence as a potential aid in addressing
causal questions and it is closely linked to the concept of Granger causality (Granger, 1969).
We note that Granger causality was initially defined in the context of discrete time series, where
suppose that there are two time series X.t/ and Y.t/, and U.t/ represents ‘all of the information
in the universe’ up to time t ∈ Z+. Then we say that X.t/ is Granger causal for Y.t/ if Y may
be better predicted at time t +1 given U.t/ than given U.t/\X.t/. Otherwise we say that X.t/ is
Granger non-causal for Y.t/. Local (in)dependence may be viewed somewhat as an extension of
the Granger causality–non-causality concept to processes in continuous time. The asymmetry
of the local independence concept makes it particularly attractive, as having one subprocess
locally influencing a change in another, but the other not having any influence on the first, is
precisely how we would like to characterize a causal effect of Yj on Yk. However, a one-sided
local dependence relationship between two subprocesses of a composable Markov process is
not sufficient to imply causation.
Aalen (1987), in extending the concept, stressed that local (in)dependence was a dynamic sta-
tistical approach which, by incorporating time explicitly, offers a natural way to model potential
causal relationships. This is reflected in other writings which take a dynamic viewpoint including
that of Arjas and Parner (2004) who not only believe that explicit accounting of the time aspect
should be made because of the time ordering of cause and effect but also because often the
durations between different events are an integral part of the causal problem and therefore of
the analysis. This viewpoint is also seen in Commenges and Gégout-Petit (2009) who developed
a general dynamical model as a framework for causal interpretation, which uses the concepts
of ‘the system’ and ‘causal influence’, is centred on stochastic processes and further builds on
the local dependence concept.
In our discussion of psoriatic arthritis disease progression that follows, we use both the
Bradford Hill criteria and Schweder’s local (in)dependence concept to reason about whether
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associations that were found in our analyses, which are based on multistate models at the indi-
vidual joint level of the hands, can be considered causal. We recognize that there are other
formal frameworks for thinking about causality (e.g. the decision theoretic (conditioning by
intervention, do-calculus), counterfactuals (potential outcomes) and causal graphs (marginal
structural models) approaches) that have been applied in the literature (Dawid, 2000; Pearl,
2000; Rubin, 1974, 1978; Robins et al., 2000). However, we believe that, for our application,
the Bradford Hill criteria and Schweder’s local (in)dependence are more natural and helpful
methods for inferring causal relationships, as our focus is not on intervention but on further
mechanistic understanding of the disease. See Aalen and Frigessi (2007) for a discussion of
mechanistic causality.
5.2. Information for causal inference
As described previously, recent work (Bond et al., 2007; Bond and Farewell, 2009) has demon-
strated that higher prior active joint counts are related to higher rates of damage development at
the patient level. Also, the differential effects of tender only and the more severe effused (usually
also tender) provide some indication of a dose–response relationship. The analyses of Sections
3 and 4 allow us to consider the extent to which these analyses performed at the individual
joint level, and the associations that may be demonstrated, aid our understanding of disease
progression and inform us additionally about causality.
In addition to the recognition that association cannot be used to prove causation, inference
about causation also needs to reflect the possibility of different causal pathways. Thus, a link
between activity and damage at the individual joint level need not preclude the involvement of
other factors nor completely separate pathways to damage.
In Section 3.2, evidence emerged of a symmetric pattern of joint damage. For a pair of joints
at the same location in the two hands, local dependences were identified in both directions
between the damage subprocesses in the left and right hands. Although these results represent
an important finding, these local dependences do not immediately warrant a causal explana-
tion, as they do not produce a one-sided (local dependence) asymmetric relationship between
the two damage subprocesses. It is quite plausible that the same underlying biological mech-
anism is driving these two damage subprocesses, although a robust biological explanation for
damage symmetry has not been put forward and tested yet. However, there are some animal
data to suggest neurological influence on inflammation (Chahl and Ladd, 1976; Denko and
Petricevic, 1978), which, as Levine et al. (1987), Helliwell et al. (2000) and Bukhari et al. (2002)
have discussed, may indicate that
‘a biological mechanism exists whereby afferent nerves from one joint can induce an inflammatory
response in the contralateral joint by inducing the release of inflammatory mediators’
(Bukhari et al., 2002). Although this explanation is somewhat speculative, it would account
for the observed but non-causal relationship of damage in one hand being associated with
subsequent damage in the other hand.
Thus, in exploring causal links between activity and damage at the individual joint level, it
must be accepted that any link will be part of a complex of factors that influence the extent of
damage seen in psoriatic arthritis patients.
However, the results in Section 3.3 do suggest
(a) joint specificity of the relationship between activity and damage;
(b) strong associations for the four statistically significant and biologically plausible local
effects obtained and, where no previous damage has occurred in either joint of a pair,
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(c) a dose–response relationship of activity with damage at the joint level (i.e. a biological
gradient).
Similar effects of tenderness and effusion, rather than a dose–response relationship, were seen
where the opposite joint of a pair exhibits damage, though we note that the damage process may
become more complex once the opposite joint is damaged, especially in light of the symmet-
ric relationships that were discussed in Section 3.2. If other causal pathways influence damage
where opposite damage exists then a dose–response relationship may be more difficult to detect.
As indicated in Section 3.3, we would consider these relationships to represent local depen-
dence of activity on damage although the activity process is not formally modelled. Here and
in Section 4 the determining of asymmetry of local dependence relationships is not specifically
addressed and is less critical because any influence of damage on subsequent activity in a joint
is of less clinical interest or, at least, represents a very different clinical question. However, as
Aalen argued, the dynamic perspective of Schweder’s work may be most important and the
analysis of Section 3.3, because of the longitudinal nature of the data, does help to characterize
the temporal relationship between activity and damage.
Therefore these results do provide support for a putative causal relationship between activ-
ity and damage. It can also be argued, we feel, that, from the perspective of both biological
plausibility and temporal ordering, this demonstrated relationship at the joint level offers more
support for a causal link than the relationships at the patient level that were seen in previous
investigations.
Results from the three-state model in Section 4 confirm that the link between activity and
damage at the individual joint level is seen even in a model which more realistically reflects
the highly variable nature of the activity process. This further strengthens the evidence for the
association and the temporal ordering and, thus, for a causal link. Moreover, although there
is some increase in the baseline transition rate from the inactive state if the joint has ever been
active, from 0.0014 to 0:0014× 3:07= 0:0043, this is much less than the rate from the active
state, 0.0304. Thus, the causal argument is enhanced since the disappearance of activity has a
similar (but negative) effect to that of the appearance of activity. We note also that in this model,
where activity is modelled in continuous time, there is no evidence to suggest that the presence
of damage in the opposite joint of a pair diminishes the increase in the transition rate to damage
from a state of activity when compared with that from a state of inactivity.
5.3. Does activity cause damage?
The determination of causality from observational data is notoriously difficult. Mathematical
formalization of the causality concept, in itself, is not enough to allow a causal relationship to
be inferred from an observed association. However, the presence of a mathematical framework
to reason about causality is helpful, if not essential, when attempting to address clinical ques-
tions of a causal nature. The multistate modelling framework provides a good illustration of
how mathematical and statistical concepts, such as local independence and local dependence,
allow causal hypotheses to be framed in a way such that they can be investigated in a statis-
tically coherent manner. Mathematical formalization together with sound application of the
Bradford Hill criteria may represent a useful strategy for inferring causality from observational
data.
Because causation cannot be proved with observational data, there can be debate about the
extent to which causality is supported. For example, activity might be regarded as an early stage
of a damage process so that their temporal ordering is simply a natural course of disease with
no causal implications. However, because activity is clearly part of an inflammatory process
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which is generally transient and damage is a condition which is irreversible and need not be
associated with concurrent inflammation, some sort of causal link appears more reasonable.
This argument is more reasonable because we have been able to demonstrate, to a considerable
degree, that this damage process will occur at the joint level. Of course, if we did not find this
joint level relationship, there might be other causal explanations for previous findings relating
patient level associations between the extent of activity and progression of damage. These argu-
ments must, however, be somewhat more complex and speculative and that is why we would
argue that the establishment of an activity–damage relationship at the joint level ‘strengthens’
the case for a causal pathway.
Similarly, investigation of the biological gradient, or dose–response, Bradford Hill criterion
can be context specific in its application. For example, most diets in the developedworld contain
sufficiently high levels of phenylalanine to induce neurological manifestations for individuals
lacking the enzyme phenylalanine hydroxylase. However, elsewhere, a dose–response relation-
ship will exist between the level of phenylalanine and the level of neurological problems. Thus
the primary risk factor for the disease phenylketonuria is binary (genetic) when the gene is rare
and a continuous dietary measure where the genetic condition is common.
One might therefore consider a ‘trigger’ hypothesis for the relationship between activity and
damage. If the onset of inflammation is all that is needed to initiate a process leading to damage,
then no dose–response or more complex temporal relationship with activity over time would
be seen. However, conversely, if we do see such relationships then such a ‘trigger’ hypothesis is
less plausible.
Previous analyses (see Bond et al. (2007) for a summary and further references) suggested
erythrocyte sedimentation rate as the most likely patient level confounder of activity and dam-
age relationship, and it was included in those analyses. As reported in Section 3.3, it did not have
a demonstrable effect in models at the joint level. The use of random effects will mitigate the
potential influence of other unmeasured confounders at the patient level. Potential confounders
measured at the individual joint level are not easily envisaged on the basis of published literature
on arthritic damage in primarily autoimmune arthritides.
Bond and Farewell (2009) also addressed the issue of potentially informative observation
times for these data. Although some evidence for such informative observation was present,
allowance for it in the study did not demonstrate any marked bias in the relationship between
activity and damage.
Thus the work that is reported here represents our effort to substantiate the well-held, but
yet unproven, claim that activity causes damage in psoriatic arthritis. Our systematic approach
to assessing this claim, which crucially relied on the analyses of activity and damage data at
the hand joint level and not only at the patient level, leads us to conclude that there is strong
epidemiological evidence for a causal relationship between activity and damage, although other
causal pathways may also be present. This conclusion is based on our results being consistent
with the majority of the Bradford Hill criteria: specificity, strength of association, biological
gradient, temporality and biological plausibility, at the joint level. Others such as consistency
and analogy have been shown at the patient (systemic) level in other psoriatic arthritis pop-
ulations and in RA populations respectively. Moreover our results do not, in any way that
we know of, conflict with generally known facts regarding the biology and natural history
of progression of disease in psoriatic arthritis patients, thus suggesting coherence. Further-
more, there are recent clinical trials that have shown that new biological therapies are effec-
tive in slowing the progression of arthritis disease. These biologics calm the inflammation of
arthritis by inhibiting the components of the immune system that trigger the inflammatory
response.
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6. Conclusion
The study of the progression of psoriatic arthritis by using multistate models has provided an
intuitive way of examining the disease process from a dynamic perspective. We considered the
damage process in the individual joints as a continuous Markov process and this was modelled
by using various multistate models over a series of discrete states. In our four-state model (Sec-
tion 3), we considered the transition intensities relating to the damage process to be functions
of the activity process at the previous visit to the clinic in each pair of hand joints. This allowed
an assessment of the influence of disease activity on joint damage, while incorporating explic-
itly the passage of time and the inherent correlation between the joints through the use of a
subject-specific random effect. Explanatory variables that are found to affect the transitions to
states of damage significantly may imply a local dependence between activity and damage, in
accordance with the work of Schweder. The three-state model (Section 4) allowed joint mod-
elling of activity and damage as continuous Markov processes and provided a further insight
into how the activity process may influence the damage process. The fit of this model suggested
strong evidence of an effect of disease activity on joint damage, again demonstrating a local
dependence between activity and damage at the individual joint level, while accounting more
appropriately for the dynamic nature of both the activity and damage processes.
Overall, the use of multistate models has proved indispensable in the assessment of local
(in)dependences in dynamic processes. Our application of these ideas at the joint level in psoriat-
ic arthritis patients has allowed us to determine the extent to which evidence of local dependence
between the activity and damage processes, together with the Bradford Hill criteria, permits a
causal link between activity and damage. We conclude, after consideration of other possible
explanations, that there is significant evidence in our analyses to suggest a causal relationship
between disease activity and clinical damage in the hand joints of patients suffering frompsoriat-
ic arthritis, although the biologicalmechanismbywhich this occurs is still to be fully understood.
Our particular attempt to move from association to causation by using Schweder’s local inde-
pendence and local dependence concepts and the Bradford Hill criteria is, to our knowledge,
one of the first comprehensive attempts along these lines at establishing causality in a well-
motivated, important and substantial medical problem. Our analyses used data from the largest
cohort of psoriatic arthritis patient followed up over time in the world, with data at the most
appropriate level (i.e. the joint level) for investigating the causal relationship between activity
and disease progression. We recommend that this approach to inferring causality from cohort
data be considered more often in the future.
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Appendix A: Likelihood derivation for four-state model
To derive the likelihood we take advantage of the fact that our model, conditional on the random effects,
is Markov. Therefore as described earlier, the contribution to the conditional likelihood, Lk.λ0,β, θ|uk/,
from the kth patient can be written as the double product of the transition probabilities, conditional on
uk, over the observed trajectories, {.x1lk, . . . , xnklk/ : l=1, . . . , 14}, followed by the joint pairs at the 14 hand
joint locations of this patient through the nk visits to the clinic, i.e.
Lk.λ0,β, θ|uk/=
14∏
l=1
nk−1∏
m=1
P{X.l/k .tk,m+1/=xm+1, lk|X.l/k .tkm/=xmlk,Uk =uk;λ.l/0 ,β.l/, z.l/k .tkm/},
where the notation used is as in Section 3.
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As we include only those patients who entered the psoriatic arthritis clinic in state 1 for all hand joint
locations, each joint pair of every patient considered in our analysis undergoes one of a possible six
observed progression paths throughout the study. These are as follows.
(a) The joint pair remains in state 1 throughout the study.
(b) The joint pair moves from state 1 to state 2 and remains in state 2 for the remainder of the study.
(c) The joint pair moves from state 1 to state 3 and remains in state 3 for the remainder of the study.
(d) The joint pair moves from state 1 to state 4 with the intermediate state, either 2 or 3, unknown.
(e) The joint pair moves from state 1 to state 2 to state 4.
(f) The joint pair moves from state 1 to state 3 to state 4.
Each of these possible progression paths yields a different contribution to the likelihood for each patient
and, because we have a relatively straightforward progressive conditional Markov model, these transition
probabilities, conditional on the subject-specific random effect, may be determined analytically.
Suppose that we have N patients under observation and we define the state i→ state j transition prob-
ability for joint pair l of the kth patient, conditional on Uk =uk, to be
p
.l/
ijk{s, t|z.l/k .s/, uk}=P{X.l/k .t/= j|X.l/k .s/= i,Uk =uk; z.l/k .s/},
for generic times t and s, with t> s. Additionally, we define the number of study observations for the lth
joint pair of the kth patient to be n.l/k of which n
.l/
ki occur in state i∈Ω={1, . . . , 4}, and henceΣ4i=1n.l/ki =n.l/k .
Next we let the n.l/ki ordered observation times corresponding to when joint pair l of patient k is in state i
be denoted by t.l/ki = .t.l/ki.1/, t.l/ki.2/, . . . , t.l/ki.n.l/
ki
/
/T.
Now, assuming that the transition intensities, conditional on the random effects, are as given in model
(1); then the transition probabilities {p.l/ijk{s, t|z.l/k .s/, uk}} in our four-state model will be as shown in
Appendix A.1. And the conditional likelihood contributions under the six possible observed progression
paths for the lth joint pair process of the kth patient are as follows.
(a) Progression path 1→1:
L
.l/
k.1→1/.λ
.l/
0 ,β
.l/, θ|t.l/k , z.l/k , uk/=
n
.l/
k1−1∏
i=1
p
.l/
11k{t.l/k1.i/, t.l/k1.i+1/|z.l/k .t.l/k1.i//, uk}:
(b) Progression path 1→2:
L
.l/
k.1→2/.λ
.l/
0 ,β
.l/, θ|t.l/k , z.l/k , uk/=
[ n.l/
k1−1∏
i=1
p
.l/
11k{t.l/k1.i/, t.l/k1.i+1/|z.l/k .t.l/k1.i//, uk}
]
p
.l/
12k{t.l/k1.n.l/
k1/
, t.l/k2.1/|z.l/k .t.l/k1.n.l/
k1/
/, uk}
×
n
.l/
k2−1∏
i=1
p
.l/
22k{t.l/k2.i/, t.l/k2.i+1/|z.l/k .t.l/k2.i//, uk}:
(c) Progression path 1→3:
L
.l/
k.1→3/.λ
.l/
0 ,β
.l/, θ|t.l/k , z.l/k , uk/=
[ n.l/
k1−1∏
i=1
p
.l/
11k{t.l/k1.i/, t.l/k1.i+1/|z.l/k .t.l/k1.i//, uk}
]
p
.l/
13k{t.l/k1.n.l/
k1/
, t.l/k3.1/|z.l/k .t.l/k1.n.l/
k1/
/, uk}
×
n
.l/
k3−1∏
i=1
p
.l/
33k{t.l/k3.i/, t.l/k3.i+1/|z.l/k .t.l/k3.i//, uk}:
(d) Progression path 1→4:
L
.l/
k.1→4/.λ
.l/
0 ,β
.l/, θ|t.l/k , z.l/k , uk/=
[ n.l/
k1−1∏
i=1
p
.l/
11k{t.l/k1.i/, t.l/k1.i+1/|z.l/k .t.l/k1.i//, uk}
]
p
.l/
14k{t.l/k1.n.l/
k1/
, t.l/k4.1/|z.l/k .t.l/k1.n.l/
k1/
/, uk}:
(e) Progression path 1→2→4:
L
.l/
k.1→2→4/.λ
.l/
0 ,β
.l/, θ|t.l/k , z.l/k , uk/=
[ n.l/
k1−1∏
i=1
p
.l/
11k{t.l/k1.i/, t.l/k1.i+1/|z.l/k .t.l/k1.i//, uk}
]
p
.l/
12k{t.l/k1.n.l/
k1/
, t.l/k2.1/|z.l/k .t.l/k1.n.l/
k1/
/, uk}
×
[ n.l/
k2−1∏
i=1
p
.l/
22k{t.l/k2.i/, t.l/k2.i+1/|z.l/k .t.l/k2.i//, uk}
]
p
.l/
24k{t.l/k2.n.l/
k2/
, t.l/k4.1/|z.l/k .t.l/k2.n.l/
k2/
/, uk}:
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(f) Progression path 1→3→4:
L
.l/
k.1→3→4/.λ
.l/
0 ,β
.l/, θ|t.l/k , z.l/k , uk/=
[ n.l/
k1−1∏
i=1
p
.l/
11k{t.l/k1.i/, t.l/k1.i+1/|z.l/k .t.l/k1.i//, uk}
]
p
.l/
13k{t.l/k1.n.l/
k1/
, t.l/k3.1/|z.l/k .t.l/k1.n.l/
k1/
/, uk}
×
[ n.l/
k3−1∏
i=1
p
.l/
33k{t.l/k3.i/, t.l/k3.i+1/|z.l/k .t.l/k3.i//, uk}
]
p
.l/
34k{t.l/k3.n.l/
k3/
, t.l/k4.1/|z.l/k .t.l/k3.n.l/
k3/
/, uk}:
Therefore the contribution to the conditional likelihood from joint pair l of the kth patient can be written
in full generality as
L
.l/
k .λ
.l/
0 ,β
.l/, θ|t.l/k , z.l/k , uk/=1{1→1}L.l/k.1→1/.λ0,β, θ|t.l/k , z.l/k , uk/+1{1→2}L.l/k.1→2/.λ0,β, θ|t.l/k , z.l/k , uk/
+1{1→3}L.l/k.1→3/.λ0,β, θ|t.l/k , z.l/k , uk/+1{1→4}L.l/k.1→4/.λ0,β, θ|t.l/k , z.l/k , uk/
+1{1→2→4}L.l/k.1→2→4/.λ0,β, θ|t.l/k , z.l/k , uk/
+1{1→3→4}L.l/k.1→3→4/.λ0,β, θ|t.l/k , z.l/k , uk/
where 1{TP} is the indicator function taking the value 1 if joint j undergoes the transition progression path
TP and 0 otherwise. Thus the overall contribution to the conditional likelihood from the kth patient may
be written as
Lk.λ0,β, θ|tk, zk, uk/=
14∏
l=1
L
.l/
k .λ
.l/
0 ,β
.l/, θ|t.l/k , z.l/k , uk/:
We account for all possible values of the random effect Uk by integrating out this term (numerically by
using R). Thus the contribution to this ‘marginal’ likelihood from the kth patient is given by
Lk.λ0,β, θ|tk, zk/=
∫ ∞
0
Lk.λ0,β, θ|tk, zk, u/fUk.u/du
where Uk ∼gamma.a, b/, with a=1=θ and b=1=θ, i.e.
fUk .u/=
baua−1 exp.−bu/
Γ.a/
= .1=θ/
1=θu1=θ−1exp.−u=θ/
Γ.1=θ/
, ∀k: .6/
Hence the likelihood function across all N patients in the study is given by
L.λ0,β, θ/=
N∏
k=1
Lk.λ0,β, θ|tk, zk/: .7/
Wemaximize function (7) with respect to the baseline intensity parameters λ0, the regression parameters
β and the variance of the random effects, θ. This is done by using the optim command in R, which yields
parameter estimates along with a numerically derived Hessian matrix at the estimate values from which
asymptotic standard errors for these estimates may be obtained.
A.1. Form of the transition probabilities
Suppose that a patient is observed at successive observation times s and t where s< t. We provide below
the analytical form of the transition probabilities pijk.s, t|zk, uk/. For convenience, we have dropped the
l-superscript in what follows:
p11k.s, t|zk, uk/= exp.−uk[λ12{β12, zk.s/}+λ13{β13, zk.s/}].t − s//;
p12k.s, t|zk, uk/= λ12{β12, zk.s/}
λ12{β12, zk.s/}+λ13{β13, zk.s/}−λ24{β24, zk.s/}
×{exp[−uk λ24{β24, zk.s/}.t − s/]
− exp.−uk[λ12{β12, zk.s/}+λ13{β13, zk.s/}].t − s//};
p13k.s, t|zk, uk/= λ13{β13, zk.s/}
λ12{β12, zk.s/}+λ13{β13, zk.s/}−λ34{β34, zk.s/}
×{exp[−ukλ34{β34, zk.s/}.t − s/]
− exp.−uk[λ12{β12, zk.s/}+λ13{β13, zk.s/}].t − s//};
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p14k.s, t|zk, uk/=1−p11k.s, t|zk, uk/−p12k.s, t|zk, uk/−p13k.s, t|zk, uk/;
p22k.s, t|zk, uk/= exp[−uk λ24{β24, zk.s/}.t − s/];
p24k.s, t|zk, uk/=1− exp[−uk λ24{β24, zk.s/}.t − s/];
p33k.s, t|zk, uk/= exp[−uk λ34{β34, zk.s/}.t − s/];
p34k.s, t|zk, uk/=1− exp[−uk λ34{β34, zk.s/}.t − s/];
p44k.s, t|zk, uk/=1:
Here
λij{βij , zk.s/}=λ0ij exp{βTij zijk.s/}
and we note that βij is the subvector of β that acts on the transition intensities from state i to state j, i.e.
βT = .βT12,βT13,βT24,βT34/.
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